Ads
related to: list of ema approved drugs for diabetes 1 treatmentexplorefrog.com has been visited by 10K+ users in the past month
consumerhippo.com has been visited by 100K+ users in the past month
consumerhorse.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
The most common side effects include urinary infections, nasopharyngitis, and upper respiratory tract infections . [5] [6] The most serious side effects include ketoacidosis (high blood levels of acids called ‘ketoacids’), pancreatitis (inflammation of the pancreas), hypersensitivity (allergic reactions) and hypoglycaemia (low blood sugar levels).
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Sotagliflozin was approved for medical use in the European Union in April 2019, as Zynquista, for the treatment for type 1 diabetes, [2] and in the United States in May 2023, [3] to reduce the risk of death due to heart failure. [1] [4] The marketing authorization for sotagliflozin was withdrawn in the EU in August 2022. [2]
Exenatide (also Exendin-4, marketed as Byetta) is the first GLP-1 agonist approved for the treatment of type 2 diabetes. Exenatide is not an analogue of GLP but rather a GLP agonist. [32] [33] Exenatide has only 53% homology with GLP, which increases its resistance to degradation by DPP-4 and extends its half-life. [34]
Pharmaceutical firm GlaxoSmithKline announced Thursday that it has filed its type-2 diabetes drug albiglutide for regulatory approval with the European Medicines Agency (EMA). Glaxo submitted the ...
Insulin icodec was approved for medical use in Canada in March 2024. [3]In March 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Awiqli, intended for the treatment of diabetes. [4]
Ads
related to: list of ema approved drugs for diabetes 1 treatmentexplorefrog.com has been visited by 10K+ users in the past month
consumerhippo.com has been visited by 100K+ users in the past month
consumerhorse.com has been visited by 100K+ users in the past month